MedPath

Improving Patient Outcome in Group Therapy for Eating Disorders

Phase 2
Conditions
Bulimia Nervosa (BN)
Binge Eating Disorder (BED)
Eating Disorder Not Otherwise Specified (EDNOS)
Interventions
Other: Group psychotherapy
Other: Group psychotherapy with feedback
Registration Number
NCT01693237
Lead Sponsor
Marianne Lau, MD, DSci.
Brief Summary

The current trial aims to investigate the impact of continuous feedback on dropout and outcome in group therapy. The hypothesis is that continuous feedback to patient and therapist on treatment progress and alliance will 1) increase adherence and 2) increase treatment outcome.

Detailed Description

Background: In the psychotherapy of eating disorders, a dropout rate between 30% and 50% is reported internationally. The fact that up to half of the patients drop out of treatment calls for ways to improve it. Research shows that feedback to patient and therapist increases outcome and reduces the number of dropouts; however there is only three published works on the effect of feedback in eating disorders treatment. Therefore, the present trial, at the eating disorders unit at Stolpegaard Psychotherapy Centre, Gentofte, Denmark, may contribute to necessary improvements in the field.

Objective: The current trial, which will be conducted from August 2012 to August 2014, aims to investigate the impact of continuous feedback on adherence and outcome in group psychotherapy. The hypothesis is that continuous feedback to patient and therapist on treatment progress and alliance will 1)increase adherence 2) increase treatment outcome.

Method: The trial is set up in a randomized design with 159 patients allocated to a) treatment with feedback intervention or b) treatment as usual.

Participants: The participants are diagnosed with Bulimia Nervosa, Binge Eating Disorder or Eating Disorder Not Otherwise Specified.

Interventions: In the experimental group, two sets of feedback measures are added to the standard treatment: Outcome Rating Scale (ORS) and Group Session Rating Scale (GSRS). The ORS assesses areas of life functioning known to change as a result of therapeutic intervention. The GSRS assesses key dimensions of effective therapeutic relationships.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
159
Inclusion Criteria
  • Aged 18 or older.
  • BMI of minimum 20.
  • Meet the diagnostic criteria for Bulimia Nervosa, Binge Eating Disorder or EDNOS according to DSM- IV.
Exclusion Criteria
  • Acute suicidal risk.
  • Psychosis.
  • Severe depression.
  • Abuse of alcohol, medicine and/or narcotics up to 3 months before referral.
  • Use of cannabis once a month is accepted at intake but must stop during treatment.
  • Concomitant psychotherapeutic/ psychiatric treatment outside Stolpegaard Psychotherapy Centre.
  • Severe or non-regulated physical co-morbidity.
  • Pregnancy.
  • Unable to understand Danish.
  • Previous participation in the current trial.
  • Considered unable to attend treatment sessions as planned.
  • Lack of informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group psychotherapyGroup psychotherapy20 sessions of systemic and narrative group psychotherapy
Group psychotherapy with feedbackGroup psychotherapy with feedback20 sessions of systemic and narrative group psychotherapy with session-to-session feedback to patient and therapist.
Primary Outcome Measures
NameTimeMethod
AdherenceAt end of treatment. Participants will be followed for the duration of treatment, an expected average of 20 weeks.

Treatment adherence in the intervention period defined as a rate, i.e., number of attended therapy sessions divided by the number of planned therapy sessions. If a patient ends therapy prematurely, and this is in accordance with the therapists, the number of attended sessions will be set equal to the planned number of sessions.

Secondary Outcome Measures
NameTimeMethod
Eating Disorders Examination InterviewAt intake, end of treatment and follow-up. Participants will be followed for the duration of treatment and follow-up, an expected average of 3 years.

Trial Locations

Locations (1)

Stolpegaard Psychotherapy Centre

🇩🇰

Gentofte, Denmark

© Copyright 2025. All Rights Reserved by MedPath